Company / Capital Expenditures
Chemed Corp. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$62.8M
FY2025
5-year range
$49.5M / $62.8M
FY2021-FY2025
Trend
+26.8%
vs FY2024
Sector context
#73 of 145
Health Care
What the data says
At $63M, Chemed Corp.'s capital expenditures ranks #73 of 145 in the Health Care sector. Capital Expenditures returned to growth in FY2025 after 4 years of decline, reaching $63M.
Based on SEC 10-K filings.
$63M in FY2025 with a 5-year CAGR of +1.3%.
Improved from $57M to $63M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- +1.3%
- 10-Year CAGR
- -
Sector benchmark
#73 of 145 in Health CareTop 50% of 145This company $62.8M Sector average $268.6M
▼
-76.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +1.3%, indicating consistent growth.
- In FY2025, capital expenditures increased 26.8% year-over-year.
- Ranks #73 out of 145 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $62.8M | +26.8% |
| FY2024 | $49.5M | -12.9% |
| FY2023 | $56.9M | -0.8% |
| FY2022 | $57.3M | -2.3% |
| FY2021 | $58.7M | -0.3% |
| FY2020 | $58.8M | +11.0% |
| FY2019 | $53.0M | +0.3% |
| FY2018 | $52.9M | -17.8% |
| FY2017 | $64.3M | +61.7% |
| FY2016 | $39.8M | -9.9% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026